No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CASI CASI Pharmaceuticals
- 6.0000
- -0.3500-5.51%
Close Jul 22 16:00 ET
- 5.8500
- -0.1500-2.50%
Post 16:01 ET
80.41MMarket Cap-2631P/E (TTM)
6.4800High5.5850Low91.55KVolume6.1700Open6.3500Pre Close555.66KTurnover1.48%Turnover RatioLossP/E (Static)13.40MShares8.480052wk High5.20P/B37.11MFloat Cap1.900052wk Low--Dividend TTM6.18MShs Float11137.4899Historical High--Div YieldTTM14.09%Amplitude1.4500Historical Low6.0690Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CASI Pharmaceuticals Freezes Juventas Assets Amid Dispute
Express News | CASI Pharmaceuticals Inc - CASI Pharmaceuticals Obtains Asset Freezing Order in Court of P.r. China Against Juventas
CASI Pharmaceuticals Welcomes New CFO
CASI Pharma Taps Athenex's Daniel Lang, MD as CFO
CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products today announces
CASI Pharmaceuticals Names Daniel Lang Chief Financial Officer >CASI
CASI Pharmaceuticals Names Daniel Lang Chief Financial Officer >CASI
Express News | CASI Pharmaceuticals Announces Appointment of Daniel Lang, Md as CFO and Svp
Comments
$CASI Pharmaceuticals(CASI.US$ to the moon
action. 
$Rivian Automotive(RIVN.US$ this one is at least moving in the right direction, $CASI Pharmaceuticals(CASI.US$
1
$CASI Pharmaceuticals(CASI.US$ pump it up so u can short it
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg